Sign in

CIK 0001410098

  • Non-accelerated filer

CorMedix Inc.

Sign in to watch
Ticker
CRMD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 908-517-9500
Business address
389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
Open-market buys, last 90 days
$588,195
in 4 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$588,195. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-02-28 TELLEZ CORA M Director Purchase +1,540 $2.10 $3K 118,071
2017-02-21 TELLEZ CORA M Director Grant or award · Stock Option (Right to Buy Common Stock) +40,000 40,000
2017-02-21 TELLEZ CORA M Director Grant or award · Restricted Stock Units +20,714 20,714
2017-02-21 Markvicka Taunia Director Grant or award · Stock Option (Right to Buy Common Stock) +40,000 40,000
2017-02-21 Markvicka Taunia Director Grant or award · Restricted Stock Units +13,571 13,571
2017-02-21 Kaplan Myron Director Grant or award · Stock Option (Right to Buy Common Stock) +40,000 40,000
2017-02-21 Kaplan Myron Director Grant or award · Restricted Stock Units +10,000 10,000
2017-02-21 GEORGE MICHAEL W Director Grant or award · Stock Option (Right to Buy Common Stock) +40,000 40,000
2017-02-21 GEORGE MICHAEL W Director Grant or award · Restricted Stock Units +12,232 12,232
2017-02-21 Dillione Janet Director Grant or award · Stock Option (Right to Buy Common Stock) +40,000 40,000
2017-02-21 Dillione Janet Director Grant or award · Restricted Stock Units +15,357 15,357
2017-02-14 GEORGE MICHAEL W Director Purchase · Phantom Stock +3,472 $7,500.00 $26.0M 3,472
2017-02-14 TELLEZ CORA M Director Purchase · Phantom Stock +3,472 $7,500.00 $26.0M 3,472
2017-02-14 Dillione Janet Director Purchase · Phantom Stock +3,472 $7,500.00 $26.0M 3,472
2017-02-07 Pfaffle Antony Chief Scientific Officer Exercise or conversion +10,000 $0.68 $7K 10,000
2017-02-07 Pfaffle Antony Chief Scientific Officer Sale −10,000 $2.00 $20K 0
2017-02-07 Pfaffle Antony Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) +10,000 70,000
2017-01-30 Abrams Judith R Chief Medical Officer Grant or award · Stock Option (Right to buy Common Stock) +165,000 165,000
2017-01-30 Abrams Judith R Chief Medical Officer Grant or award · Stock Option (Right to buy Common Stock) +185,000 185,000
2017-01-30 Cook Robert W. Chief Financial Officer Grant or award · Stock Option (Right to buy Common Stock) +165,000 165,000

Page 22 of 24 · 463 trades